Loading clinical trials...
Loading clinical trials...
To determine if the reduction in TMPRSS2 activity via direct inhibition with Camostat mesilate combined with standard of care (SOC) treatment will increase the proportion of patients alive and free fr...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Alan Bryce
NCT05543616 · SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, and more
NCT04516811 · COVID-19, SARS-CoV-2 Infection, and more
NCT06409663 · Severe Acute Respiratory Syndrome Coronavirus 2 Infection
NCT04402957 · COVID, Severe Acute Respiratory Syndrome, and more
NCT05677893 · Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)
Mayo Clinic in Arizona
Scottsdale, Arizona
Tucson Medical Center
Tucson, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions